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Fluorescently tagged polymer bioconjugates from protein derived
macroinitiators{
Julien Nicolas,a Veronica San Miguel,b Giuseppe Mantovania and David M. Haddleton*a
BSA
 
and
 
lysozyme
 
have
 
been transformed into macroinitiators for living radical polymerisation and used to produce well-
defined bioconjugates which can be fluorescently labelled providing a versatile strategy for the preparation of bioconju-
gates
 
which
 
is
 
complementary
 
to
 
traditional
 
PEGylation.
Protein–polymer conjugation provides an established method to
develop protein and peptide therapeutics. The most significant
example is undoubtedly the covalent modification of proteins with
poly(ethylene glycol) (PEG), ‘‘PEGylation’’.1 The resulting con-
jugates exhibit a number of advantages including improved bio-
distribution and pharmacokinetics, reduced immunogenicity and
longer plasma half-life from both reduced renal filtration and
proteolysis, when compared to non-PEGylated analogues.1 The
emergence of living radical polymerisation (LRP)2 has provided an
efficient tool to finely tune the nature and the characteristics of
many synthetic polymers. We have recently reported works
involving the ‘‘grafting to’’ strategy for the synthesis of bioconju-
gates, the traditional way to bioconjugates via PEGylation.
a-Functional well-defined polymers were shown as alternative
PEGylation agents and conjugated with residual amine (lysine and
N-terminal a-amino residues) and thiol (cysteine residues)
functionalities present at the surface of the proteins.3 In contrast,
the ‘‘grafting from’’ synthetic route, which consists of transforming
a protein into a macroinitiator for subsequent polymerisation, has
not been as deeply investigated.4 This is interesting as this is the
method commonly used from non-biological surfaces.5
Herein, we report a strategy for the synthesis of fluorescent
bioconjugates by LRP from protein macroinitiators. Materials
containing fluorescent tags are useful allowing observation via
fluorescence microscopy and in particular laser scanning confocal
microscopy. This is crucial for tracing in biological systems during
biomedical assays as the location of the material can be finely
observed. Our idea was to incorporate a fluorescent probe in situ
during the conjugate synthesis using fluorescent monomers under
copolymerisation conditions with poly(ethylene glycol) methyl
ether methacrylate (PEGMA475) or dimethylaminoethyl metha-
crylate (DMAEMA). For this purpose, we used a hostasol
methacrylate monomer6 and synthesized a new methacrylate
monomer derived from Rhodamine B (Scheme 1). The method
described by Francis et al.7 demonstrated the preparation of a
Rhodamine B-based alcohol which was transformed into the
corresponding methacrylate monomer.{ This synthetic route was
chosen for three main reasons: (i) contrary to the rhodamine-
secondary amides, the tertiary amides avoid intramolecular
cyclisation which would result in a loss of fluorescence; (ii) this
compound is freely soluble in aqueous solutions whilst retaining its
fluorescence emission under a broad range of pH and (iii) it allows
enlargement of our range of fluorescent starting materials. The
resulting Rhodamine B monomer exhibited a lex. = 566 nm and a
lem. = 587 nm, with a Stokes shift of 21 nm, in agreement with the
spectral properties previously reported for the Rhodamine
B-tertiary amide derivatives.7
Bovine serum albumin (BSA) is a y66 kDa commercially
available protein selected as a model protein to demonstrate this
approach. The synthetic route for the synthesis of a fluorescent
bioconjugate is shown in Scheme 2. The synthesis of the BSA–
protein macroinitiator targeted the free cysteine residue (Cys-34) as
reactive towards the maleimide. Although only approximately 40–
60% of free cysteine was available due to partial oxidation,8 this
route allowed the conjugation of one BSA protein per polymer
chain as opposed to a statistical multi-site attachment as previously
reported.4
All synthetic steps to the fluorescent bioconjugate were
monitored by sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS-PAGE) (Fig. 1). The BSA macroinitiator exhibited
two bands: the most significant being slightly greater than 66 kDa
and a broad band ranging from 200 kDa to higher molecular
weight. This is explained by aggregation of unreduced BSA caused
by intermolecular thiol–disulfide interchange reaction, which
induces the formation of BSA oligomers and thus of higher
molecular weight compounds.9
Aggregation of BSA may also induce some conformational
changes, especially accompanying the decrease of the a-helix and
an increase of b-sheet content.9 Circular dichroism (CD) analysis
of native BSA and BSA-macroinitiator indicated that the a-helix
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Scheme 1 Rhodamine B (left) and hostasol (right) methacrylate
fluorescent monomers used in this work.
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content decreased from 54 to 43% whilst the b-sheet content
increased from 1 to 8%, respectively.{ This confirmed a
conformational difference between native BSA and BSA-macro-
initiator due to the presence of BSA oligomers, which may also be
ascribed to the attachment of the initiator group to the BSA.
Differentiation between native BSA and BSA-macroinitiator
was achieved by RP-HPLC with a linear gradient.{ Complete
disappearance of the native BSA peak (tR = 17.0 min) was
observed together with the appearance of the peak of the BSA-
macroinitiator (tR = 19.5 min). A very small peak observed at tR =
14.6 min may probably be due to traces of BSA oligomers. The
isolated BSA-macroinitiator was used to initiate the polymerisa-
tion of both PEGMA475 and DMAEMA using copper-mediated
living radical copolymerisation with either hostasol or rhodamine
fluorescent monomers. The bioconjugates were purified and
isolated by dialysis and lyophilisation. Bioconjugation was
monitored by SDS-PAGE (with both white light and UV) where
a complete shift of the BSA-macroinitiator to higher molecular
weight was observed with all monomers (Fig. 1). As expected, all
bioconjugates exhibited intense fluorescence{ in accordance with
the respective excitation/emission spectra of the rhodamine and
hostasol fluorescent monomers (Fig. 2).
For both monomers (PEGMA475 and DMAEMA{{), the
fluorescent bioconjugates obtained could be detected by SEC-
HPLC equipped with a fluorescence detector (at appropriate lex.
and lem. for each monomer) (Fig. 3). This confirmed that the
fluorescent probes were incorporated into the conjugates during
the polymerisation process.
To demonstrate the flexibility of this approach, a similar
synthetic route was investigated with lysozyme. In this case, the
free amine groups were targeted for multi-site attachment with
N-succinimidyl 2-bromo-2-methylpropionate (Scheme 3).
The lysozyme-macroinitiator was isolated, characterised{ and
used to initiate the copolymerisation of PEGMA475 in aqueous
solution with rhodamine monomer using living radical polymer-
isation. The bioconjugation was monitored by SDS-PAGE (Fig. 4)
and the recovered fluorescent bioconjugate, lysozyme-
poly(PEGMA475-co-rhodamine), was observed by SEC-HPLC
via fluorescence detection (lex. = 566 nm and lem. = 596 nm),
Fig. 1 SDS-PAGE of native BSA (a), BSA-macroinitiator (b), BSA-
poly(DMAEMA-co-rhodamine) (c), BSA-poly(PEGMA475-co-rhod-
amine) (d) and BSA-poly(PEGMA475-co-rhodamine) under UV at l =
302 nm (e).
Fig. 2 Absorption (dashed line) and emission (solid line) spectra of BSA-
poly(PEGMA475-co-hostasol) and BSA-poly(PEGMA475-co-rhodamine)
fluorescent bioconjugates. Inserts: pictures of BSA-poly(PEGMA475-co-
hostasol) (a) and BSA-poly(PEGMA475-co-rhodamine) (b) bioconjugates
in phosphate buffer solution (10 mM, pH = 7.1).
Fig. 3 SEC-FL-HPLC of BSA-poly(PEGMA475-co-rhodamine) biocon-
jugate (a) and Rhodamine B methacrylate (b).
Scheme 2 Synthetic strategy for the BSA–maleimide macroinitiator and
subsequent living radical polymerisation of PEGMA475 and fluorescent
monomers. Reagents and conditions: (a) phosphate buffer (100 mM, pH =
7.0)/DMSO (96/4; v/v), 25 uC, 12 h; (b) Cu(I)Br/N-(ethyl)-2-pyridylmetha-
nimine, PEGMA475, Rhodamine B methacrylate, H2O, 25 uC, N2, 48 h.
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which demonstrated the incorporation of the fluorescent probe
in situ during polymerisation (Fig. 5).
Contrary to the BSA bioconjugates, via SEC-FL-HPLC were
seen: (i) the higher retention time of the lysozyme bioconjugate
(tR,BSA = 22 min and tR,lysozyme = 32 min) due to an initial
difference of molecular weight (y66 kDa for BSA and y14.3 kDa
for lysozyme); (ii) the broad peak from the lysozyme bioconjugate,
probably due to the multi-site attachment of the lysozyme-
macroinitiator which induced a broader molar mass distribution as
regularly observed in living radical polymerisation involving
multifunctional initiator.
In summary, both bovine serum albumin (BSA) and lysozyme
proteins were transformed into efficient macroinitiators for the
synthesis of fluorescent bioconjugates from living radical poly-
merisation. A new fluorescent methacrylate monomer based on
Rhodamine B was designed and synthesised. These bioconjugates
were observed by fluorescence detection SEC-HPLC; allowing for
in situ observation of the products.
We thank Prof. Alison Rodger and Dr Matthew Hicks for
fruitful discussions as well as Rajan Kumar Randev for his kind
help.
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{ It is noted that DMAEMA hydrolyses rapidly in pure water to
methacrylic acid and the amino alcohol, however, this is suppressed by
buffering at pH = 6.6 such that ,1% hydrolysis occurs after 93 h,
detectable by 400 MHz 1H NMR.
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Scheme 3 Synthetic strategy for the lysozyme-N-hydroxysuccinimide
initiator and subsequent living radical polymerisation of PEGMA475 and
rhodamine monomer. Reagents and conditions: (a) Phosphate buffer
(100 mM, pH = 7.0), DMSO/TEA (95/5; v/v), 25 uC, 48 h; (b) Cu(I)Br/N-
(Ethyl)-2-pyridylmethanimine, PEGMA475, Rhodamine B methacrylate,
H2O, 25 uC, N2, 48 h.
Fig. 4 SDS-PAGE of native lysozyme (a), lysozyme-macroinitiator (b),
lysozyme-poly(PEGMA475-co-rhodamine) (c), and lysozyme-
poly(PEGMA475-co-rhodamine) under UV at l = 302 nm (d).
Fig. 5 SEC-FL-HPLC of lysozyme-poly(PEGMA475-co-rhodamine)
fluorescent bioconjugate (a) and Rhodamine B methacrylate (b).
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